4.4 Article

Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: a case-control study

Alicia Gonzalez-Martinez et al.

Summary: Headache is a common manifestation in COVID-19 patients, with 13% of cases experiencing it. Factors associated with headache include younger age, fewer comorbidities, and reduced mortality. Headache often presents as an early symptom with distinct characteristics.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Letter Medicine, General & Internal

Sequelae in Adults at 6 Months After COVID-19 Infection

Jennifer K. Logue et al.

JAMA NETWORK OPEN (2021)

Article Clinical Neurology

Toward a better understanding of persistent headache after mild COVID-19: Three migraine-like yet distinct scenarios

Edoardo Caronna et al.

Summary: Studies show that post-COVID headache encompasses various types of headaches, requiring careful evaluation and further investigation into different underlying pathophysiological mechanisms.

HEADACHE (2021)

Article Multidisciplinary Sciences

Frequency and phenotype of headache in covid-19: a study of 2194 patients

David Garcia-Azorin et al.

Summary: Headache occurred in 23.4% of patients with confirmed COVID-19, being more intense in females. Headache was the most frequent first symptom of COVID-19, with characteristics of being bilateral with pressing quality and typically lasting for 7 days.

SCIENTIFIC REPORTS (2021)

Article Clinical Neurology

Neurologic manifestations in hospitalized patients with COVID-19 The ALBACOVID registry

Carlos Manuel Romero-Sanchez et al.

NEUROLOGY (2020)

Letter Medicine, General & Internal

Persistent Symptoms in Patients After Acute COVID-19

Angelo Carfi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Clinical Neurology

Headache as a Cardinal Symptom of Coronavirus Disease 2019: A Cross-Sectional Study

Javier A. Membrilla et al.

HEADACHE (2020)

Article Public, Environmental & Occupational Health

Ninety days post-hospitalization evaluation of residual COVID-19 symptoms through a phone call check list

Miguel Suarez-Robles et al.

PAN AFRICAN MEDICAL JOURNAL (2020)

Review Physiology

PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING

Peter J. Goadsby et al.

PHYSIOLOGICAL REVIEWS (2017)

Article Clinical Neurology

Clinical and prognostic subforms of new daily-persistent headache

M. S. Robbins et al.

NEUROLOGY (2010)

Review Medicine, General & Internal

Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration

Jan P. Vandenbroucke et al.

PLOS MEDICINE (2007)

Article Clinical Neurology

What incites new daily persistent headache in children?

KJ Mack

PEDIATRIC NEUROLOGY (2004)